{"id":639,"date":"2019-07-20T21:43:57","date_gmt":"2019-07-20T14:13:57","guid":{"rendered":"http:\/\/bioactivecompoundlibrary.com\/?p=639"},"modified":"2022-01-11T17:15:56","modified_gmt":"2022-01-11T09:45:56","slug":"characterized-functional-antigen-plasma-levels-c1-inh-arise","status":"publish","type":"post","link":"http:\/\/bioactivecompoundlibrary.com\/index.php\/2019\/07\/20\/characterized-functional-antigen-plasma-levels-c1-inh-arise\/","title":{"rendered":"Characterized by low functional and antigen plasma levels of C1-inh that can arise"},"content":{"rendered":"<p>Whereas HAE type II patients are characterized by low functional, but normal or increased antigen C1-inh plasma levels. This classification has however been challenged by observations of intermediary HAE types, when small amounts of dysfunctional C1-inh is present in the blood stream. As no evidence regarding clinical consistencies between the type I and type II patients have been observed, this classification describes as such, only the <img src=\"http:\/\/www.abmole.com\/upload\/structure\/Nutlin-3a-chemical-structure.gif\" align=\"left\" width=\"228\" style=\"padding:10px;\"\/>biochemical profile of HAE patients. Both types of patients suffer from episodic swellings, where bradykinin is suspected to play a central role. The edema formation is primarily caused by a transient increased BK release from high molecular weight kininogen. The BK release is mediated by uncontrolled activation of the coagulation factor XII dependent kallikrein kinin system. C1-inh circulates in plasma in a stressed high energetic metastable conformation, which is characterized by a reactive center loop protruding from the central part of the serpin. The amino acid sequence of the RCL serves as a bait region for a limited number of proteases. When a protease recognizes and cleaves the P1\ufffdCP19 scissile bond in the RCL, the RCL domain inserts into the central beta-sheet A of C1-inh together with the covalently attached protease. After cleavage C1-inh obtains a low energetic stable conformation, and the protease is irreversibly inhibited. Polymerized C1-inh represents another stable and low energetic conformation, which can be attained upon mutations in the SERPING1 gene. A few studies have in vitro addressed the ability of mutated C1-inh to form polymers. The studies focused on distinct mutations resulting in C1-inh polymerization, and recombinantly expressed mutated C1-inh proteins were utilized to demonstrate polymerization of the C1-inh in vitro. For example Zahedi et al. demonstrated that the C1-inh mutant C1-inh-Ta had an increased propensity to polymerize when expressed recombinantly. One group did observe a multimeric form of C1-inh in fractions from sucrose gradient centrifugation of a patient plasma sample, and this suggested that C1-inh polymers might exist in the plasma of HAE patients. Extracellular serpin polymers have been observed in other <a href=\"http:\/\/www.abmole.com\/products\/azd2281.html\">AZD2281<\/a> diseases involving mutations in serpin encoding genes. A classic example hereof is the presence of a1-antitrypsin polymers in lung lavage of patients suffering from the Z-mutation in the a1-antitrypsin encoding gene. The clinical relevance of C1-inh polymers in the plasma of HAE patients remains hitherto uncertain, and therefore we aimed to elucidate the presence and nature of C1-inh polymers in plasma from HAE patients. In the present study we aimed to elucidate whether certain HAE genotypes produced C1-inh polymers identified with a specific monoclonal antibody. All Danish HAE families were tested for a putative polymerized C1-inh phenotype. We demonstrated that C1-inh polymers were present in plasma of six HAE patients in three of 31 HAE families affected by different SERPING1 mutations. In vitro experiments using <a href=\"http:\/\/www.abmole.com\/products\/ly2157299.html\">LY2157299 citations<\/a> recombinant C1-inh strategy have demonstrated that certain C1-inh mutations are prone to polymerization, but these experiments did not demonstrate the presence of polymerized C1-inh in patient plasma. Others have used patient plasma samples subjected to gel filtration or sucrose density gradient centrifugation analysis or C1-inh purified from patient plasma, and the results of these studies advocate for the presence of polymeric C1-inh in patient plasma. However, the presence of C1-inh polymers in untreated patient plasma samples has not previously been demonstrated. C1-inh polymers were detected in HAE patient plasma samples, with determination of the sizes of the polymers.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Whereas HAE type II patients are characterized by low functional, but normal or increased antigen C1-inh plasma levels. This classification has however been challenged by observations of intermediary HAE types, when small amounts of dysfunctional C1-inh is present in the blood stream. As no evidence regarding clinical consistencies between the type I and type II&hellip; <a class=\"more-link\" href=\"http:\/\/bioactivecompoundlibrary.com\/index.php\/2019\/07\/20\/characterized-functional-antigen-plasma-levels-c1-inh-arise\/\">Continue reading <span class=\"screen-reader-text\">Characterized by low functional and antigen plasma levels of C1-inh that can arise<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[1],"tags":[],"_links":{"self":[{"href":"http:\/\/bioactivecompoundlibrary.com\/index.php\/wp-json\/wp\/v2\/posts\/639"}],"collection":[{"href":"http:\/\/bioactivecompoundlibrary.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/bioactivecompoundlibrary.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/bioactivecompoundlibrary.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"http:\/\/bioactivecompoundlibrary.com\/index.php\/wp-json\/wp\/v2\/comments?post=639"}],"version-history":[{"count":1,"href":"http:\/\/bioactivecompoundlibrary.com\/index.php\/wp-json\/wp\/v2\/posts\/639\/revisions"}],"predecessor-version":[{"id":640,"href":"http:\/\/bioactivecompoundlibrary.com\/index.php\/wp-json\/wp\/v2\/posts\/639\/revisions\/640"}],"wp:attachment":[{"href":"http:\/\/bioactivecompoundlibrary.com\/index.php\/wp-json\/wp\/v2\/media?parent=639"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/bioactivecompoundlibrary.com\/index.php\/wp-json\/wp\/v2\/categories?post=639"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/bioactivecompoundlibrary.com\/index.php\/wp-json\/wp\/v2\/tags?post=639"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}